Published in J R Soc Interface on December 06, 2014
The biology and function of fibroblasts in cancer. Nat Rev Cancer (2016) 1.16
Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis. Front Oncol (2015) 1.15
Tumor Budding: The Name is EMT. Partial EMT. J Clin Med (2016) 1.00
Stability of the hybrid epithelial/mesenchymal phenotype. Oncotarget (2016) 0.99
Stemness of the hybrid Epithelial/Mesenchymal State in Breast Cancer and Its Association with Poor Survival. PLoS One (2015) 0.99
OVOL guides the epithelial-hybrid-mesenchymal transition. Oncotarget (2015) 0.93
Epithelial Mesenchymal Transition: a double-edged sword. Clin Transl Med (2015) 0.92
Jagged-Delta asymmetry in Notch signaling can give rise to a Sender/Receiver hybrid phenotype. Proc Natl Acad Sci U S A (2015) 0.91
Coupling the modules of EMT and stemness: A tunable 'stemness window' model. Oncotarget (2015) 0.86
Cell Fate Decision as High-Dimensional Critical State Transition. PLoS Biol (2016) 0.83
Preclinical safety and efficacy studies with an affinity-enhanced epithelial junction opener and PEGylated liposomal doxorubicin. Mol Ther Methods Clin Dev (2015) 0.79
Computational Model of MicroRNA Control of HIF-VEGF Pathway: Insights into the Pathophysiology of Ischemic Vascular Disease and Cancer. PLoS Comput Biol (2015) 0.79
Jagged mediates differences in normal and tumor angiogenesis by affecting tip-stalk fate decision. Proc Natl Acad Sci U S A (2015) 0.79
Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis. Sci Rep (2015) 0.78
Mesenchymal-Epithelial Transition in Sarcomas Is Controlled by the Combinatorial Expression of MicroRNA 200s and GRHL2. Mol Cell Biol (2016) 0.78
Phenotypic plasticity in prostate cancer: role of intrinsically disordered proteins. Asian J Androl (2016) 0.77
EMT and MET: necessary or permissive for metastasis? Mol Oncol (2017) 0.77
Inflammatory breast cancer: a model for investigating cluster-based dissemination. NPJ Breast Cancer (2017) 0.76
The emerging roles of Oct4 in tumor-initiating cells. Am J Physiol Cell Physiol (2015) 0.76
Boolean network model for GPR142 against Type 2 diabetes and relative dynamic change ratio analysis using systems and biological circuits approach. Syst Synth Biol (2015) 0.76
Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface (2016) 0.76
Stem Cell Plasticity And Niche Dynamics in Cancer Progression. IEEE Trans Biomed Eng (2016) 0.75
Transcriptional and Post-Transcriptional Regulation of Thrombospondin-1 Expression: A Computational Model. PLoS Comput Biol (2017) 0.75
Cell dynamics in tumour environment after treatments. J R Soc Interface (2017) 0.75
A Theoretical Model of the Wnt Signaling Pathway in the Epithelial Mesenchymal Transition. Theor Biol Med Model (2017) 0.75
Phenotypic Plasticity and Cell Fate Decisions in Cancer: Insights from Dynamical Systems Theory. Cancers (Basel) (2017) 0.75
Epithelial plasticity and cancer stem cells: Major mechanisms of cancer pathogenesis and therapy resistance. World J Stem Cells (2017) 0.75
Clinically relevant morphological structures in breast cancer represent transcriptionally distinct tumor cell populations with varied degrees of epithelial-mesenchymal transition and CD44(+)CD24(-) stemness. Oncotarget (2017) 0.75
Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells. BMC Cancer (2017) 0.75
Epithelial-mesenchymal plasticity: How have quantitative mathematical models helped improve our understanding? Mol Oncol (2017) 0.75
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet (2000) 21.52
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science (2013) 10.87
An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell (2009) 10.09
Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One (2008) 8.97
A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell (2010) 7.94
Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell (2014) 4.44
NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene (2006) 3.91
Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci U S A (2009) 3.76
Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev (2013) 3.63
Bifurcation dynamics in lineage-commitment in bipotent progenitor cells. Dev Biol (2007) 3.49
Circulating tumor cells from patients with advanced prostate and breast cancer display both epithelial and mesenchymal markers. Mol Cancer Res (2011) 3.25
Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol (2011) 2.76
Tumor metastasis: moving new biological insights into the clinic. Nat Med (2013) 2.71
Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells. PLoS One (2010) 2.63
Tackling the cancer stem cells - what challenges do they pose? Nat Rev Drug Discov (2014) 2.55
Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Reports (2013) 2.47
Negative autoregulation of c-myc transcription. EMBO J (1990) 2.38
Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol (2005) 2.21
Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer (2011) 2.19
Epithelial-to-mesenchymal transitions in the liver. Hepatology (2009) 1.99
Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res (2011) 1.96
Identification of adult hepatic progenitor cells capable of repopulating injured rat liver. Hepatology (2008) 1.93
LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance. Mol Cell (2012) 1.93
Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells. Nucleic Acids Res (2009) 1.93
Nanog overcomes reprogramming barriers and induces pluripotency in minimal conditions. Curr Biol (2010) 1.86
Autoregulation of microRNA biogenesis by let-7 and Argonaute. Nature (2012) 1.85
Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells. Cancer Res (2010) 1.78
MAP3K4/CBP-regulated H2B acetylation controls epithelial-mesenchymal transition in trophoblast stem cells. Cell Stem Cell (2011) 1.71
Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol Biol Cell (2007) 1.61
MicroRNA-based regulation of epithelial-hybrid-mesenchymal fate determination. Proc Natl Acad Sci U S A (2013) 1.60
Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative. Cancer Res (2011) 1.54
myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation (2010) 1.50
Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS One (2011) 1.50
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis (2013) 1.49
Plasticity of disseminating cancer cells in patients with epithelial malignancies. Cancer Metastasis Rev (2012) 1.47
Reduced Oct4 expression directs a robust pluripotent state with distinct signaling activity and increased enhancer occupancy by Oct4 and Nanog. Cell Stem Cell (2013) 1.42
Epithelial and mesenchymal subpopulations within normal basal breast cell lines exhibit distinct stem cell/progenitor properties. Stem Cells (2012) 1.35
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer. PLoS One (2013) 1.32
Stat3-coordinated Lin-28-let-7-HMGA2 and miR-200-ZEB1 circuits initiate and maintain oncostatin M-driven epithelial-mesenchymal transition. Oncogene (2013) 1.32
Constitutive activation of nuclear factor-kappaB is preferentially involved in the proliferation of basal-like subtype breast cancer cell lines. Cancer Sci (2009) 1.31
Multistable decision switches for flexible control of epigenetic differentiation. PLoS Comput Biol (2008) 1.27
Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition. RNA (2013) 1.27
EMT 2.0: shaping epithelia through collective migration. Curr Opin Genet Dev (2009) 1.25
NF-kappaB oscillations and cell-to-cell variability. J Theor Biol (2005) 1.25
Critical regulation of miR-200/ZEB2 pathway in Oct4/Sox2-induced mesenchymal-to-epithelial transition and induced pluripotent stem cell generation. Proc Natl Acad Sci U S A (2013) 1.21
Breast cancer stem cells and epithelial mesenchymal plasticity - Implications for chemoresistance. Cancer Lett (2013) 1.18
Tristability in cancer-associated microRNA-TF chimera toggle switch. J Phys Chem B (2013) 1.10
Glomerular parietal epithelial cells of adult murine kidney undergo EMT to generate cells with traits of renal progenitors. J Cell Mol Med (2011) 1.08
A general model for binary cell fate decision gene circuits with degeneracy: indeterminacy and switch behavior in the absence of cooperativity. PLoS One (2011) 1.06
The EMT universe: space between cancer cell dissemination and metastasis initiation. Crit Rev Oncog (2014) 1.05
Toward decoding the principles of cancer metastasis circuits. Cancer Res (2014) 1.05
MYC protein inhibits transcription of the microRNA cluster MC-let-7a-1~let-7d via noncanonical E-box. J Biol Chem (2011) 1.02
Regulation of the let-7a-3 promoter by NF-κB. PLoS One (2012) 1.02
Cancer stem cells, a fuzzy evolving concept: a cell population or a cell property? Cell Cycle (2013) 0.97
Why are cellular switches Boolean? General conditions for multistable genetic circuits. J Theor Biol (2009) 0.93
The three-way switch operation of Rac1/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition. Sci Rep (2014) 0.92
Evidence for a common progenitor of epithelial and mesenchymal components of the liver. Cell Death Differ (2013) 0.90
Helicobacter pylori initiates a mesenchymal transition through ZEB1 in gastric epithelial cells. PLoS One (2013) 0.87
Epidermal growth factor (EGF)-induced corneal epithelial wound healing through nuclear factor κB subtype-regulated CCCTC binding factor (CTCF) activation. J Biol Chem (2013) 0.86
The three-way switch operation of Rac1/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition. Sci Rep (2014) 0.92
Periodic, Quasi-periodic and Chaotic Dynamics in Simple Gene Elements with Time Delays. Sci Rep (2016) 0.77
Notch-Jagged signalling can give rise to clusters of cells exhibiting a hybrid epithelial/mesenchymal phenotype. J R Soc Interface (2016) 0.76